Olmesartan Medoxomil/Amlodipine orotate

N/A

Report date: 2026/02/05 10:48:30

Base Information

Drug NameOlmesartan Medoxomil/Amlodipine orotate
Drug Alias NameAmlodipine orotate+Olmesartan medoxomilAmlodipine orotate/Olmesartan medoxomilOlmesartan medoxomil+Amlodipine orotateSevisartanG-3041
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2014/10/30
Country/TerritorySouth Korea
CombinationsYes Olmesartan MedoxomilAmlodipine Orotate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDong-A ST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A ST Co Ltd
Inactive CompaniesDong-A Pharmaceutical Co Ltd
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksN/A